Prostate Cancer Clinical Trial

Magnetic Resonance Imaging and Spectroscopy of the Prostate

Summary

Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

prostate cancer patients willing to undergo a MRI and MRSI exam

Exclusion Criteria:

patients with prostate cancer and bone or lymph node metastasis
patients who can not have an MRI exam

Study is for people with:

Prostate Cancer

Estimated Enrollment:

1005

Study ID:

NCT00590993

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

1005

Study ID:

NCT00590993

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider